TrivarX Ltd. engages in clinical research, product development, and early-stage commercialization of mental health technology. Its product is used to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in 1998 and is headquartered in South Melbourne, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company